– Reuters
Alpha Tau Submits To Japanese PMDA For Pre-Market Approval Of Alpha DaRT In Patients With Recurrent Head And Neck Cancer
Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ:DRTS, DRTSW)))), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and HekaBio K.K. ("HekaBio") a Japan-based healthcare investment,
